INDBInternet News Database 2.5 Updated just now · 293 sources Show or hide images Light or dark

Remdesivir in Immunocompromised Patients: Survival Benefit?

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

Among hospitalized patients with weakened immune systems, a single day or two of timing appeared to separate diverging survival curves. Nearly half never received the drug at all.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Remdesivir in Immunocompromised Patients: Survival Benefit?

    Among hospitalized patients with weakened immune systems, a single day or two of timing appeared to separate diverging survival curves. Nearly half never received the drug at all.

Comments

Comments need JavaScript.